Global Health Limited Market Cap ($3.85 Billion)
Market Cap & Net Worth: Global Health Limited (MEDANTA)
Global Health Limited market cap. Global Health Limited (NSE:MEDANTA) has a market capitalization of $3.85 Billion (Rs356.27 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #4090 globally and #182 in its home market, demonstrating a 9.39% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Global Health Limited's stock price Rs1325.80 by its total outstanding shares 268721832 (268.72 Million). Also see cash flow conversion of Global Health Limited for how efficiently the company converts equity into cash flow.
Global Health Limited Market Cap History (2022–2026)
Global Health Limited market cap history from 2022 to 2026. Data shows growth from $1.36 Billion to $3.85 Billion (33.99% CAGR). Check MEDANTA stock price and chart for real-time trading data and today's change.
Index Memberships
Global Health Limited is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.02 Trillion | 0.13% | #168 of 500 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$662.84 Billion | 0.58% | #76 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.09 Trillion | 0.35% | #93 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.10 Trillion | 0.12% | #164 of 750 |
Weight: Global Health Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Global Health Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Global Health Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Global Health Limited (MEDANTA) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.09x
Global Health Limited's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.69x
Global Health Limited's market cap is 0.69 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.36 Billion | $21.67 Billion | $1.96 Billion | 0.06x | 0.69x |
| 2023 | $2.79 Billion | $26.83 Billion | $3.26 Billion | 0.10x | 0.85x |
| 2024 | $3.13 Billion | $32.41 Billion | $4.78 Billion | 0.10x | 0.66x |
| 2025 | $3.45 Billion | $36.37 Billion | $4.81 Billion | 0.09x | 0.72x |
| 2026 | $3.85 Billion | $44.10 Billion | $5.56 Billion | 0.09x | 0.69x |
Competitor Companies of MEDANTA by Market Capitalization
Companies near Global Health Limited in the global market cap rankings as of November 4, 2026. Also see MEDANTA total asset value for a full breakdown of the balance sheet.
Key companies related to Global Health Limited by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #283 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #903 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #985 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1213 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #283 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $462.86 |
| #903 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €48.81 |
| #985 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1213 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $266.69 |
Market Capitalization of Global Health Limited (2022–2026)
Market capitalization of Global Health Limited from 2022 to today. Between 2022 and today, Global Health Limited's market cap moved from $1.36 Billion to $ 3.85 Billion, with a yearly change of 33.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs3.85 Billion | +11.75% |
| 2025 | Rs3.45 Billion | +10.00% |
| 2024 | Rs3.13 Billion | +12.44% |
| 2023 | Rs2.79 Billion | +104.60% |
| 2022 | Rs1.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Global Health Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.85 Billion USD |
| MoneyControl | $3.85 Billion USD |
| MarketWatch | $3.85 Billion USD |
| marketcap.company | $3.85 Billion USD |
| Reuters | $3.85 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emerg… Read more